An average price reduction of 56%!

In accordance with the "Notice of the Joint Conference Office of the Centralized Procurement of Medicines and Medical Consumables of Jiangxi Province on the Implementation of the Results of the Fifth Batch of National Organizations for the Centralized Procurement and Use of Drugs", all public medical and health institutions in Jiangxi Province and medical institutions in the army stationed in Jiangxi will be issued on October 18, 2021 Starting at midnight on the day, the fifth batch of state-organized drugs for centralized procurement and use of Jiangxi selected results and medical insurance payment standards will be fully implemented
.
In order to do a good job in the implementation of the fifth batch of nationally organized drugs for centralized drug procurement, and to ensure that medical institutions purchase and supply selected drugs in a timely manner, after research, it has been decided to open the online procurement qualification for selected drugs in advance from 0:00 on October 17, 2021
.
All relevant pharmaceutical production and operation enterprises and medical institutions are requested to log in to the Jiangxi Pharmaceutical Procurement Service Platform in a timely manner to carry out the online procurement of selected drugs in the fifth batch of nationally organized pharmaceutical centralized procurement
.
For non-selected products that have been announced that meet the price requirements, online procurement qualifications will be opened together; for non-selected products that have not declared prices and declared prices that do not meet the requirements, online procurement qualifications will be suspended
.
It is understood that the 61 drugs involved in the fifth batch of national centralized procurement cover common diseases such as high blood pressure, coronary heart disease, diabetes, gastrointestinal diseases, drugs for chronic diseases, and drugs for major diseases such as lung cancer, breast cancer, and colorectal cancer.
Organizing the largest number of centralized drug collections, the average price of 61 drugs was reduced by 56%, and the treatment costs for patients related to centralized collections will be significantly reduced
.
In terms of commonly used drugs, taking the acute gastric ulcer treatment drug esomeprazole injection as an example, the price has dropped from 65 yuan/bottle to about 4 yuan/bottle, and a treatment cycle can save 610 yuan in drug costs
.
The price of the new-generation diabetes drug saxagliptin has been reduced by 62%, and the monthly cost has been reduced from 225 yuan to less than 90 yuan
.
The state's organization of centralized drug procurement is a major measure to deepen the reform of the medical and health system and solve the difficulty and expensive medical care of the people
.